Literature DB >> 2476197

Neurons of the substantia nigra reticulata receive a dense GABA-containing input from the globus pallidus in the rat.

Y Smith1, J P Bolam.   

Abstract

The lectin Phaseolus vulgaris leucoagglutinin (PHA-L) was used as an anterograde tracer to study the topographical distribution and synaptic organization of pallidonigral fibres in the rat. Injections of PHA-L in the lateral part of the globus pallidus led to anterograde labelling of a rich plexus of varicose fibres that arborized profusely in the central core of the rostral three quarters of the substantia nigra pars reticulata (SNr). However, few fibres were detected in SNr after PHA-L injection restricted to the most medial part of the globus pallidus. A small number of fibres was seen in the substantia nigra pars compacta after each injection. The most characteristic feature of the pallidonigral terminals was the formation of baskets around the perikarya and primary dendrites of SNr cells. Electron microscopic analysis revealed that the pallidonigral terminals contain pleomorphic vesicles and a large number of mitochondria and that they form symmetrical synaptic contacts. Furthermore, postembedding immunocytochemistry for gamma-aminobutyric acid (GABA) showed that they display GABA immunoreactivity. These findings demonstrate that, in the rat, the pallidonigral projection is a major source of GABA-containing terminals innervating pars reticulata cells and that the pattern of innervation is such that they may exert a powerful inhibitory control over these cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476197     DOI: 10.1016/0006-8993(89)91011-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  28 in total

Review 1.  Synaptic organisation of the basal ganglia.

Authors:  J P Bolam; J J Hanley; P A Booth; M D Bevan
Journal:  J Anat       Date:  2000-05       Impact factor: 2.610

2.  Subthalamic-pallidal interactions are critical in determining normal and abnormal functioning of the basal ganglia.

Authors:  Andrew Gillies; David Willshaw; Zhaoping Li
Journal:  Proc Biol Sci       Date:  2002-03-22       Impact factor: 5.349

3.  Electrophysiological and morphological characteristics of three subtypes of rat globus pallidus neurone in vitro.

Authors:  A J Cooper; I M Stanford
Journal:  J Physiol       Date:  2000-09-01       Impact factor: 5.182

Review 4.  Intrinsic and integrative properties of substantia nigra pars reticulata neurons.

Authors:  F-M Zhou; C R Lee
Journal:  Neuroscience       Date:  2011-08-02       Impact factor: 3.590

5.  Activity of neurochemically heterogeneous dopaminergic neurons in the substantia nigra during spontaneous and driven changes in brain state.

Authors:  Matthew T C Brown; Pablo Henny; J Paul Bolam; Peter J Magill
Journal:  J Neurosci       Date:  2009-03-04       Impact factor: 6.167

6.  The Basal Ganglia as a Substrate for the Multiple Actions of Amphetamines.

Authors:  Reka Natarajan; Bryan K Yamamoto
Journal:  Basal Ganglia       Date:  2011-07-01

7.  Synaptic integration of functionally diverse pallidal information in the entopeduncular nucleus and subthalamic nucleus in the rat.

Authors:  M D Bevan; N P Clarke; J P Bolam
Journal:  J Neurosci       Date:  1997-01-01       Impact factor: 6.167

8.  Transgenic mouse lines subdivide external segment of the globus pallidus (GPe) neurons and reveal distinct GPe output pathways.

Authors:  Kevin J Mastro; Rachel S Bouchard; Hiromi A K Holt; Aryn H Gittis
Journal:  J Neurosci       Date:  2014-02-05       Impact factor: 6.167

Review 9.  GABA neurons in seizure disorders: a review of immunocytochemical studies.

Authors:  C R Houser
Journal:  Neurochem Res       Date:  1991-03       Impact factor: 3.996

10.  Involvement of Basal Ganglia network in motor disabilities induced by typical antipsychotics.

Authors:  Jonathan Chetrit; Bérangère Ballion; Steeve Laquitaine; Pauline Belujon; Stéphanie Morin; Anne Taupignon; Bernard Bioulac; Christian E Gross; Abdelhamid Benazzouz
Journal:  PLoS One       Date:  2009-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.